• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

SARS ‑CoV‑2: Review of Conditions Associated With Severe Disease and Mortality
In conclusion, this article explain s the association between diseases mentioned above and the severity of COVID‑19 and clearly shows the population at risk. This paper will help government bodies and decision‑makers prioritize resources for these populations to reduce mortality rates and overall quality of life.
Source: International Journal of Preventive Medicine - October 15, 2022 Category: International Medicine & Public Health Source Type: research

Antimicrobial Resistance Calls for Brainpower of a Space Agency and Campaigning Zeal of an NGO
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Source: IPS Inter Press Service - Health - November 17, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

COVID-19  patients in Germany: exposure risks and associated factors for hospitalization and severe disease
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Jul 29:1-9. doi: 10.1007/s00103-021-03391-0. Online ahead of print.ABSTRACTThe severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) spread worldwide in 2020. By the end of June 2021, over 3.7 million people had been infected in Germany. The spread of the infection, however, is not evenly distributed across all parts of the population. Some groups are at a higher risk for SARS-CoV‑2 infections or severe coronavirus disease 2019 (COVID-19) trajectories than others.This narrative review provides an overview of the parts of the population in Ger...
Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - July 30, 2021 Category: International Medicine & Public Health Authors: Uwe Koppe Hendrik Wilking Thomas Harder Walter Haas Ute Rexroth Osamah Hamouda Source Type: research

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)
AbstractThe novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the early stage, we have issued “A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)”; now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based guideline. W...
Source: Military Medical Research - September 3, 2020 Category: International Medicine & Public Health Source Type: research

Important Information for Human Cell, Tissue, or Cellular or Tissue-based Product (HCT/P) Establishments Regarding the 2019 Novel Coronavirus Outbreak
Source: U.S. Food and Drug Administration (FDA). Published: 2/14/2020. While respiratory viruses, in general, are not known to be transmitted by implantation, transplantation, infusion, or transfer of human cells, tissues, or cellular or tissue-based products (HCT/Ps), the potential for transmission of COVID-19 (2019 novel coronavirus) by HCT/Ps is unknown at this time. According to this information from the Food and Drug Administration (FDA), there have been no reported cases of transmission of COVID-19 via these products. The FDA will continue to monitor the situation and will issue updates as information becomes available. (Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news